Showing results (2281-2290 of 6,777) with videos related to

Sort By:
Pageof 678
Clinical Therapeutics|March 15, 2011
Concurrent control of blood glucose, body mass, and blood pressure in patients with type 2 diabetes: an analysis of data from electronic medical recordsCarrie McAdam-Marx, Jonathan Bouchard, Mark Aagren, et al.
Clinical Therapeutics|March 15, 2011
Medication adherence affects treatment modifications in patients with type 2 diabetesJaco Voorham, Flora M Haaijer-Ruskamp, Bruce H R Wolffenbuttel, et al.
Clinical Therapeutics|March 15, 2011
Bioavailability of three rufinamide oral suspensions compared with the marketed 400-mg tablet formulation: results from a randomized-sequence, open-label, four-period, four-sequence crossover study in healthy subjectsDavid John Critchley, Jagadeesh Aluri, Peter Boyd, et al.
Clinical Therapeutics|June 4, 2011
Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German settingChristian Asseburg, Martin Frank, Claus-Henning Köhne, et al.
Clinical Therapeutics|November 1, 1990
An endoscopic evaluation of the effects of etodolac and diclofenac on the gastric and duodenal mucosaA van Eeden, R H Schotborgh, G N Tytgat
Clinical Therapeutics|April 19, 2011
Effects of copayment on initiation of smoking cessation pharmacotherapy: an analysis of varenicline reversed claimsFeng Zeng, Chieh-I Chen, Vera Mastey, et al.
Clinical Therapeutics|May 24, 2011
Cost-effectiveness of zoledronic acid in the management of skeletal metastases in patients with lung cancer in France, Germany, Portugal, the Netherlands, and the United kingdomAvani D Joshi, John A Carter, Marc F Botteman, et al.
Clinical Therapeutics|May 24, 2011
Comparison of preference for NovoPen(®) 4 with previous insulin pen treatments after 12 weeks in adult patients with type 1 and type 2 diabetes: a multicenter observational studyHarma Israël-Bultman, Jacob Hyllested-Winge, Marcin Kolaczynski, et al.
Clinical Therapeutics|June 28, 2011
Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetesGeorge Dailey
Clinical Therapeutics|June 28, 2011
Effects of food intake on the pharmacokinetic properties of dalcetrapib: findings from three phase I, single-dose crossover studies in healthy volunteersMichael Derks, Hitoshi Kawamura, Markus Abt, et al.
Pageof 678